Creatine monohydrate powder
“Supports strength gains when combined with resistance training.”
Single-ingredient creatine monohydrate, 5 g daily; healthy men aged 18–49 following a progressive resistance-training program.
Strong support for a focused, training-qualified claim.
Executive summary
The research supports this focused strength claim for the defined creatine and resistance-training scenario. Retain the wording with its training condition. The complete text-only sample ad presents lower concern within the U.S. federal screen.
Illustrative ratings for this example only. Scores apply to the exact submitted claims, not the proposed alternatives. These are evidence-based judgments, not probabilities of efficacy, compliance or enforcement.
| Submitted claim | Confidence | Risk | Recommended path |
|---|---|---|---|
| Supports strength gains when combined with resistance training. | 8/10 · Strong | 3/10 · Lower | retain with conditions |
Claim 1 · Best defensible scientific position
Human trials synthesized in the reviewed full texts support additional strength gains from creatine monohydrate alongside resistance training. A qualitative claim, a studied daily amount and a closely matched adult audience provide a defensible bridge to this single-ingredient sample.
[PMID:39519498] [PMID:40944139] [PMID:42765482]
Why 8/10: Study quality, formula fit and claim fit each earn 2 points. Variable endpoints and a targeted review of selected full texts each earn 1. The resulting 8/10 reflects strong support for this specific scenario.
- Study quality: 2/2. Full-text syntheses of controlled human training trials report positive pooled strength effects; the 2024 review reports generally good trial quality. This sample relies on the reviews’ trial appraisals.
- Consistency and totality: 1/2. Positive strength findings recur, but not across every test. Null outcomes, publication bias and trial overlap limit consistency.
- Form, dose and product fit: 2/2. The defined single-ingredient monohydrate formula and 5 g/day amount match regimens in the 2024 review. This is a scenario match, not verification of an actual batch or customer formula.
- Outcome, population and claim fit: 2/2. The qualitative strength outcome, resistance-training condition and healthy male audience align with the research, without promising a magnitude or deadline.
- Source access and research coverage: 1/2. Three relevant review full texts were accessed, including a September 2026 publication. The search was targeted and underlying trials were not independently reappraised.
What limits or could strengthen this position
- Some strength outcomes are null, and benefits vary. The reviews share underlying trials; they are not three independent sets of clinical replications.
- This targeted source review is not an exhaustive search or an independent appraisal of every trial. A real product requires verification against the scenario assumptions.
Confidence rubric: Five factors, each scored 0–2: study quality, consistency, product fit, claim fit and research coverage. Total 1–10, with evidence/access ceilings. 1–2 minimal; 3–4 limited; 5–6 moderate; 7–8 strong; 9–10 very strong. Even 10 is not certainty.
Risk rubric: 1–3 lower; 4–6 moderate; 7–8 high; 9–10 very high. The most material assessed concern controls the score. An unassessed in-scope check makes the score provisional and at least 4; it is not an established violation.
The complete sample advertisement
“Creatine monohydrate. 5 g daily for healthy men aged 18–49. Supports strength gains when combined with resistance training.”
Placement: Standalone, text-only U.S. advertisement; separate from product labeling and point-of-sale materials. This defined presentation contains only the text above, with equal prominence for the audience and training condition, and no images, testimonials or additional claims.
Scenario assumptions: The formula is exactly as described. No real product records or finished-product trial were supplied; these ratings evaluate the defined scenario and cannot be transferred to an unverified customer product.
Regulatory summary · Advertising & label claims
Market: United States federal dietary supplement advertising and label-claim screen
Placement: Standalone, text-only U.S. advertisement; separate from product labeling and point-of-sale materials.
Policy sources checked: October 8, 2026 (UTC)
Retain the focused claim in this defined advertising scenario. The separate checks below explain the lower risk rating and the placement limits.
Claim 1 · Regulatory Risk 3/10 — Lower
Claim category: structure function
Lower concern applies to the complete sample text and stated placement. Research fits the limited benefit, and the training condition is explicit. This judgment does not cover other advertising or a product label.
The sample describes normal physical performance, without disease or nutrient-content language.
Next step: Preserve this claim category when adapting the sample.
Reviewed human evidence fits the defined formula and qualitative strength benefit. Residual evidence limits support a 3 rather than a minimal-risk rating.
Next step: Keep substantiation and product-match records before use.
The full sample text states the audience, daily amount and training condition. Its defined presentation includes no extra promises, images or testimonials.
Next step: Reassess the complete presentation whenever copy or creative changes.
This scenario is a standalone advertisement, not labeling or point-of-sale material. No label compliance is inferred.
Next step: For labeling use, separately assess applicable FDA disclaimer and notification conditions.
The defined ad includes no disease-risk, nutrient-content or endorsement claim.
Next step: Assess any such additions separately.
Screening limits
State-specific requirements, non-U.S. markets, marketplace and ad-platform policies, a complete label audit, and product safety are not assessed.
- These are sample-specific editorial judgments, not agency grades or clearance of a live customer advertisement.
- Formula identity and the complete text-only presentation are explicitly defined assumptions. A real submission with missing in-scope materials would receive a provisional rating.
Authoritative sources consulted
- FTC Health Products Compliance Guidance — Agency guidance
- FDA Structure/Function Claims — Agency explanation of labeling requirements
- FDA Label Claims for Conventional Foods and Dietary Supplements — Agency explanation of claim categories
This scoped screen does not certify compliance. A strong scientific case does not independently establish that wording is permissible in a particular market or placement.
Your recommended next steps
1 retain with conditions
Start with the actions marked Before use. Candidate wording is provisional and depends on the conditions below; it is not final advertising approval.
Claim 1: Supports strength gains when combined with resistance training.
Recommended wording to evaluate
Supports strength gains when combined with resistance training.
Why this is the recommended path: The qualitative claim fits the strength outcomes, monohydrate form and training context represented in the reviewed human research. A numerical gain or deadline is unnecessary to communicate the supported benefit.
[PMID:39519498] [PMID:40944139] [PMID:42765482]
Conditions and unresolved checks
- The rating applies to the defined single-ingredient, 5 g/day sample and adult male training audience. Product identity and composition are scenario assumptions, not verified customer records.
- Keep the training condition in the claim. Adding guaranteed results, a timeframe, disease wording, testimonials or other creative elements requires a fresh assessment.
- Before use — Match a real product and advertisement to the assessed scenario.
Done when: The product specification confirms monohydrate and 5 g/day, and the complete advertisement matches the audience, training condition and qualitative benefit evaluated here.
- To strengthen — Keep the substantiation file current.
Done when: Relevant full-text trials and updates are retained, including null findings, population limits and the reasons they do or do not change this claim.
Evidence strength
Full-text reviews of human trials support additional strength gains alongside resistance training. The claim makes no numerical, deadline or universal-results promise.
Product applicability
The defined single-ingredient formula uses the studied monohydrate form and a daily amount represented in resistance-training trials. The specified adult male audience closely matches the best-represented population.
Evidence boundaries
Benefits vary across strength tests and individuals. Findings do not establish every outcome, every population or a guaranteed response.
Scientific rationale
Evidence is strongest for a qualitative strength claim tied to resistance training. Consistent positive pooled results across several reviews support that position, while null endpoints and differences between trials keep confidence below the top band.
Wording recommendation
Retain the training-qualified wording for the defined sample. Reassess if the formula, audience, dose, claim or advertising context changes.
Scientific sources and access
Full texts checked October 8, 2026 through Europe PMC. The reviews overlap in their underlying trials; study counts must not be added together as independent evidence.
Effects of Creatine Supplementation and Resistance Training on Muscle Strength Gains in Adults <50 Years of Age
A systematic review of 23 randomized trials found additional upper- and lower-body strength gains with creatine plus resistance training versus placebo plus training. Included regimens cover 5 g/day, including trials without loading.
Limitations: Training and dosing varied; women were underrepresented. The review identified possible publication bias for upper-body outcomes. Underlying trials were not independently reappraised for this sample.
PubMed · PMID:39519498 ↗ · Read the full text ↗The Effects of Creatine Supplementation on Upper- and Lower-Body Strength and Power
This broader review of 69 studies reports benefits for selected strength and power outcomes, including bench/chest press and squat strength.
Limitations: Pooled handgrip and leg-press results were not statistically significant. Population, training and dosing differed between studies. One author disclosed creatine-related commercial relationships.
PubMed · PMID:40944139 ↗ · Read the full text ↗Resistance training combined with creatine supplementation: a three-level meta-analysis of multidimensional outcomes
A three-level meta-analysis of 63 trials found additional upper- and lower-body strength gains with creatine and resistance training; its model accounts for multiple outcomes within studies.
Limitations: Small trials, uneven population coverage, varied training and incomplete dietary reporting limit precision. Publication-bias adjustment reduced the upper-body effect, which remained positive.
PubMed · PMID:42765482 ↗ · Read the full text ↗Keep the claim aligned with the evidence
- Keep the resistance-training condition with the benefit claim.
- Match any real product to the stated ingredient identity, daily amount and intended audience.
- Retain the evidence file and assess new research or changes to the advertisement.
Method and limitations
This sample uses a targeted review of three published review full texts and the dated FTC/FDA references above. It is not an exhaustive literature search, an independent trial-level risk-of-bias appraisal, a safety assessment or legal advice. Ratings reflect the defined formula, audience, claim and placement. Different materials can produce different results, including findings that require revision.